Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124641932 | 12464193 | 2 | F | 201511 | 20160705 | 20160614 | 20160707 | EXP | US-GLAXOSMITHKLINE-US2016GSK083035 | GLAXOSMITHKLINE | 73.69 | YR | M | Y | 0.00000 | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124641932 | 12464193 | 1 | PS | COREG | CARVEDILOL | 1 | Oral | 12.5 MG, BID | Y | 20297 | 12.5 | MG | TABLET | BID | |||||
| 124641932 | 12464193 | 2 | SS | ELIQUIS | APIXABAN | 1 | Oral | 5 MG, BID | 420 | MG | Y | 0 | 5 | MG | BID | ||||
| 124641932 | 12464193 | 3 | C | GARLIC. | GARLIC | 1 | Oral | 200 MG, QD | Y | 0 | 200 | MG | QD | ||||||
| 124641932 | 12464193 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, QD | Y | 0 | 81 | MG | QD | ||||||
| 124641932 | 12464193 | 5 | C | FISH OIL | FISH OIL | 1 | Oral | 1000 MG, QD | Y | 0 | 1000 | MG | QD | ||||||
| 124641932 | 12464193 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG, QD | Y | 0 | 40 | MG | QD | ||||||
| 124641932 | 12464193 | 7 | C | NONI JUICE | NONI FRUIT JUICE | 1 | Oral | 3000 MG, QD | Y | 0 | 3000 | MG | QD | ||||||
| 124641932 | 12464193 | 8 | C | SAW PALMETTO | SAW PALMETTO | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
| 124641932 | 12464193 | 9 | C | VIAGRA | SILDENAFIL CITRATE | 1 | 100 MG, PRN | Y | 0 | 100 | MG | ||||||||
| 124641932 | 12464193 | 10 | C | SOTALOL HYDROCHLORIDE. | SOTALOL HYDROCHLORIDE | 1 | Oral | 120 MG, BID | Y | 0 | 120 | MG | BID | ||||||
| 124641932 | 12464193 | 11 | C | LECITHIN | LECITHIN | 1 | Oral | 1 G, QD | Y | 0 | 1 | G | QD | ||||||
| 124641932 | 12464193 | 12 | C | TAMSULOSIN HYDROCHLORIDE. | TAMSULOSIN HYDROCHLORIDE | 1 | 0.4 MG, QD | Y | 0 | .4 | MG | QD | |||||||
| 124641932 | 12464193 | 13 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
| 124641932 | 12464193 | 14 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | 400 IU, QD | Y | 0 | 400 | IU | QD | ||||||
| 124641932 | 12464193 | 15 | C | WHEY | WHEY | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124641932 | 12464193 | 1 | Atrial fibrillation |
| 124641932 | 12464193 | 2 | Atrial fibrillation |
| 124641932 | 12464193 | 9 | Erectile dysfunction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124641932 | 12464193 | OT |
| 124641932 | 12464193 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124641932 | 12464193 | Aphasia | |
| 124641932 | 12464193 | Atrial fibrillation | |
| 124641932 | 12464193 | Blood creatine phosphokinase increased | |
| 124641932 | 12464193 | Bradycardia | |
| 124641932 | 12464193 | Cerebrovascular accident | |
| 124641932 | 12464193 | Dyspnoea | |
| 124641932 | 12464193 | Haemorrhagic transformation stroke | |
| 124641932 | 12464193 | Hypotonia | |
| 124641932 | 12464193 | Systolic dysfunction | |
| 124641932 | 12464193 | Tachycardia | |
| 124641932 | 12464193 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124641932 | 12464193 | 2 | 20151113 | 20151225 | 0 |